Position in ABSI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,459,875
-$3,701,267 QoQ
Shares Held
486,625
-67.1% QoQ
Ownership
0.312%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 44.30577960441819.ToString("F0")%
Shared 0.ToString("F0")%
None 55.694220395581816.ToString("F0")%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. ABSI ranks #231 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ABSI
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,459,875 | 486,625 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,161,142 | 1,478,838 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $2,948,396 | 969,868 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $3,210,642 | 1,249,278 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,659,162 | 1,457,835 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,210,822 | 462,147 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,916,513 | 501,706 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $410,179 | 133,176 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $751,909 | 132,379 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $202,733 | 48,270 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $62,717 | 47,515 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $144,625 | 95,149 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $205,009 | 117,149 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $227,381 | 108,278 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $280,359 | 89,572 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $176,227 | 53,081 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $207,462 | 24,610 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $141,826 | 17,296 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $33,901 | 2,915 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||